Safety, acceptability, and adherence to dapivirine vaginal ring and oral pre-exposure prophylaxis for HIV prevention in the second trimester of pregnancy: a multicountry, open-label, phase 3b randomised trial.

Mhlanga FG, Szydlo DW, Mayo AJ, Bunge K, Fairlie L, Nakabiito C, Musara P, Mgodi NM, Dadabhai S, Scheckter R, Anderson PL, Marzinke MA, Chappell C, Gadama LA, Richardson BA, Piper JM, Hillier SL, MTN-042 DELIVER study team

Open source

DOI
10.1016/s2352-3018(25)00307-8
Published
2026 Mar
Container
The lancet. HIV
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s2352-3018-25-00307-8,
  title = {Safety, acceptability, and adherence to dapivirine vaginal ring and oral pre-exposure prophylaxis for HIV prevention in the second trimester of pregnancy: a multicountry, open-label, phase 3b randomised trial.},
  author = {Mhlanga FG and Szydlo DW and Mayo AJ and Bunge K and Fairlie L and Nakabiito C and Musara P and Mgodi NM and Dadabhai S and Scheckter R and Anderson PL and Marzinke MA and Chappell C and Gadama LA and Richardson BA and Piper JM and Hillier SL and MTN-042 DELIVER study team},
  year = {2026},
  journal = {The lancet. HIV},
  doi = {10.1016/s2352-3018(25)00307-8},
  url = {https://doi.org/10.1016/s2352-3018(25)00307-8}
}

RIS

TY  - JOUR
TI  - Safety, acceptability, and adherence to dapivirine vaginal ring and oral pre-exposure prophylaxis for HIV prevention in the second trimester of pregnancy: a multicountry, open-label, phase 3b randomised trial.
AU  - Mhlanga FG
AU  - Szydlo DW
AU  - Mayo AJ
AU  - Bunge K
AU  - Fairlie L
AU  - Nakabiito C
AU  - Musara P
AU  - Mgodi NM
AU  - Dadabhai S
AU  - Scheckter R
AU  - Anderson PL
AU  - Marzinke MA
AU  - Chappell C
AU  - Gadama LA
AU  - Richardson BA
AU  - Piper JM
AU  - Hillier SL
AU  - MTN-042 DELIVER study team
PY  - 2026
JO  - The lancet. HIV
DO  - 10.1016/s2352-3018(25)00307-8
UR  - https://doi.org/10.1016/s2352-3018(25)00307-8
ER  - 

APA

FG, M., DW, S., AJ, M., K, B., L, F., C, N., P, M., NM, M., S, D., R, S., PL, A., MA, M., C, C., LA, G., BA, R., JM, P., SL, H., & team, M. D. S. (2026). Safety, acceptability, and adherence to dapivirine vaginal ring and oral pre-exposure prophylaxis for HIV prevention in the second trimester of pregnancy: a multicountry, open-label, phase 3b randomised trial.. The lancet. HIV. https://doi.org/10.1016/s2352-3018(25)00307-8

Source records